Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Mark Terry
The best books where science is trying to kill us all!
When it comes to tech thrillers, I can be a sucker for exotic locations—Antarctica, the Amazon, a deep-sea trench—and in the case of Lincoln Child’s Deep Storm, a top-secret military undersea research station. There’s a feeling of deep mysteries—not only are many people working at the station showing up with unexplainable medical problems, but the nature of the mystery being investigated doesn’t make sense.
Labguru (BioData) Partners with SAP to Provide its Lab Data Management Solution via the SAP Store
BOSTON, Sept. 19, 2023 /PRNewswire/ -- BioData today revealed that Labguru, its all-encompassing Lab Data Management solution, is now accessible on SAP® Store, the digital marketplace for SAP and Software Partner Providers. The addition to the SAP store will increase the ease with which customers can access Labguru, ensuring more life science companies can streamline lab operations and increase collaboration. Labguru is compatible with SAP S/4HANA and SAP Quality Management.
With Pandemic in Rearview Mirror, BriaCell Charges Ahead with Cancer Immunotherapy
BioBuzz by Workforce Genetics By Mark Terry April 25, 2023 Many biopharma companies had to place their clinical trials on hold during the first part of the COVID-19 pandemic or shift to some sort of virtual or hybrid model. Not many companies, however, were listed on the Nasdaq with plans to initiate clinical trials within days of the global economy shutting down. BriaCell did just that and is now charging ahead with pivotal clinical trials in the immuno-oncology space.
SVB Collapse Appears to Only Have Minor Ripples for BioHealth Capital Region and Greater Philly’s Biotech Scene
BioBuzz by Workforce Genetics While the impact for this event might not be as bad as anticipated, it sends a warning to companies to brace selves for an unpredictable future By Mark Terry, with contributions from Alex Keown and Sarah Ellinwood March 14, 2023 The collapse of Silicon Valley Bank (SVB) on Friday, March 10, sent shockwaves through the tech and biotech world.
Towards Youth-Centred Planetary Health Education
This is an early access version, the complete PDF, HTML, and XML versions will be available soon. Open AccessArticle by Kate C.
Californians Leaving the Golden State In Search Of New Opportunity
LAKE FOREST, CALIFORNIA, UNITED STATES, October 18, 2022 / EINPresswire.com/ -- For years, California has been known as a place of opportunity – a land of dreams where people from all over the world come to make their fortune. But the tables have turned indeed. The Golden State is no longer the land of milk and honey it once was. A report by real estate site Zillow found that droves of Californians are leaving for states like Texas, Virginia, Washington and Florida. The reason?
Terry Moving & Storage Opens 200 Brand-New Storage Vaults in Forest Lake, California Original
The move will enable the company to expand and offer additional units to residents and businesses in the central and northern parts of the state. LAKE FOREST, CALIFORNIA, UNITED STATES, August 11, 2022 / EINPresswire.com/ -- Terry Moving & Storage is pleased to announce it has opened 200 brand-new and quality-built storage units in Lake Forest, California.
Apple Jumps After Beating Top & Bottom Line; Solid iPhone Sales And China Performance
Published: Jul 28, 2022 By Mark Terry BioSpace Thursday morning, Takeda reported its quarterly sales ending June 30, 2022. The company reported a 2.4% increase in revenue for the quarter from the same period in 2021, as well as changes to its pipeline, including a decision to drop a cancer therapeutic developed with Turnstone Biologics. It is returning the rights to TAK-605 to Turnstone Biologics only 31 months after licensing the drug. TAK-605 is an oncolytic virus designed to treat cancer.
Omicron sub-variants BA.4, BA.5 make up more than 50% of U.S. COVID cases
New study: COVID-19 may cause or accelerate neurological diseases Published: Jun 28, 2022 By Mark Terry BioSpace Danish researchers published a study suggesting that COVID-19 increases the risk of neurodegenerative diseases such as Alzheimer's and Parkinson's disease. They presented the research at the European Academy of Neurology (EAN) Congress in Vienna, and the results were published in Frontiers in Neurology.
what to know about your rights when an employer lets you go
Pharma advertising has long been considered second-tier when compared to the rest of the advertising industry. And there are some legitimate reasons why. Nike sneakers and Coca-Cola soda ads will likely always be more entertaining or exciting than regulated campaigns for diabetes and heart disease. Still, the Cannes Lions advertising festival of creativity was pharma and healthcare advertising's annual chance to shine.
Unlike 1-day VRBPAC-to-EUA timeline of peers, Novavax's Covid-19 jab awaits FDA review of recent manufacturing data
Moderna, Pfizer/BioNTech and Johnson & Johnson all received FDA clearance for their Covid-19 vaccines a day after the agency's advisors recommended emergency authorization. The same will not happen for Novavax. The regulator's outside experts recommended 21 to 0 on Tuesday afternoon to give an emergency green light to the Maryland biotech's vaccine, but more than 36 hours later, an official OK hasn't been handed down yet.
Novavax delayed again, Moderna's bivalent vaccine, and more breakthrough cases
Published: Jun 09, 2022 By Mark Terry BioSpace Sadly, the COVID-19 pandemic is still with us, despite the accessibility of effective vaccines and treatments. Here's a look at some of the latest COVID-19 news. Novavax Vaccine Decision Delayed After the U.S. Food and Drug Administration's vaccines advisory panel voted to recommend Novavax's COVID-19 vaccine for an emergency use authorization (EUA), most everyone expected a fast decision by the agency.
Maze raises $40M to help facilitate software product research
Product research generally involves determining whether an idea for a new product might be successful and how to best develop and sell that product. It's a straightforward process, in theory, but the basic definition belies the barriers that can crop up. Research is often costly - software-as-a-service companies spend an 23% of their revenue on R&D, for example - and there's no guarantee that it'll lead to a successful outcome.
ECB's Lagarde Threads Needle Of Rate-Hikes Amid EU Defragmentation & Stagflation Forecast
Following The ECB's statement, traders have moved rate-hike expectations up to around 150bps by December 2022... All eyes will now be on what Lagarde says at the press conference as she tries to thread a needle of a fragmenting European bond market, ending bond-buying, and hiking rates into her own stagflationary forecast (lower growth and higher inflation).
Moderna says new bivalent COVID-19 vaccine tops Spikevax
Credit: Cincinnati Children's Scientists discovered years ago that newborn infants depend upon immune components transferred from their mothers to survive the onslaught of pathogens that begin invading their bodies as soon as they are born. Eventually, children develop their own immune systems, built through surviving natural exposures to viruses and bacteria, and augmented by a phalanx of well-established childhood vaccines.
Good News for Las Vegas Strip Casinos May Be Bad News for You
One of Disney World's most popular "rides" is returning on June 29. Traveling around Walt Disney World Resort's 27,000 acres often requires guests to carefully plan transportation choices to arrive at their destinations in a timely manner. Disney World's Monorail provides guests with a highway in the sky on three lines, the Express Line, Epcot Line and the Resort Line. The Express Line transports guests to stops at Magic Kingdom transportation and ticket center and at Magic Kingdom.
Twitter will hide false tweets from high-profile accounts during times of crisis
Life sciences companies shore up resources as US confirms first monkeypox case Published: May 19, 2022 By Hayley Shasteen On Wednesday evening, a man in Massachusetts became the first person reported to have a case of monkeypox in the U.S. since 2021. The man contracted monkeypox after traveling to Canada, although Quebec's Ministry of Health and Social Services told CBC News that no cases had been reported to the agency.
Omicron BA.2 persists while vaccines lower risk of long COVID
Xi Jinping's true aim, in my view, isn't to severely limit the spread of the coronavirus, seeking its ultimate eradication, rather to curtail dissent particularly any views contrary to his handling of China's Days ago, out of the blue a top policymaker - make that increasingly desperate economy. Mao's Xi's purpose is to completely eliminate all opposition. This intentional security policy has now been extended to the People's Bank of China itself.
Could Elon Musk really solve world hunger instead of buying Twitter?
E-commerce giant Amazon and automaker Ford both have stakes in a company that is becoming a financial headache. Amazon and Ford operate in two different sectors. The first is in online commerce, streaming, sport and, above all, cloud computing, an El Dorado that Microsoft and Google also battle for. As for Ford, after decades of focusing on making vehicles with internal combustion engines, Dearborn has focused on transforming itself into a manufacturer of electric vehicles.
AstraZeneca plans new US R&D hub as revenues rocket
AstraZeneca has revealed plans to set up a new strategic R&D hub in Cambridge, Massachusetts as it reported a massive increase in first-quarter revenues, driven by COVID-19 and oncology drugs and heart failure therapy Farxiga. The new site will be at Kendall Square and will serve as the new corporate headquarters for Alexion - which is currently based across the Charles River in Boston's Seaport District - as well as housing around 1,500 R&D staff from AZ and Alexion in a new purpose-built space.
Gilead's Covid-19 treatment Veklury props up first quarter gains amid $2.7B Trodelvy writedown
Gilead got a sales boost from its Covid-19 treatment for the first quarter - to the tune of $1.5 billion. The likely temporary bump came just in time though as Gilead reassessed its cancer drug Trodelvy's value and took a $2.7 billion R&D impairment charge. The anticipated reckoning for Trodelvy came after a Phase III readout last month that met its primary endpoint, but left analysts questioning the lack of details.
People who self-harmed during the COVID-19 pandemic may have been less likely to seek help and have found it harder to access in-patient treatment, according to study of over 3.5 million Welsh citizens
Another biotech has joined the ranks of the reorganized, as Duchenne player Solid Biosciences reported a new way of doing things Wednesday and announced layoffs and a C-suite departure. Solid Bio is reducing its workforce by 35%, according to an SEC filing for its first-quarter results Wednesday, in addition to a new emphasis on its two gene therapies.
SBFM) Upwards Bound as Biotech Reports 2 of its Newly Designed mRNA Molecules Effectively Destroy Cancer Cells Grown in Culture.
Sunshine Biopharma, Inc. (NASDAQ: SBFM) has been on a volatile rise since the Company successfully closed an $8 million public offering and was up listed to the Nasdaq Capital Market from the OTCQB.
In "Huge Win For Border Security", Court Temporarily Blocks Biden Admin From Lifting 'Title 42'
Morale among Border Patrol agents is at an "all-time low" as they face massive, unprecedented border numbers as well as a looming end to the Title 42 public health order, which is expected to further fuel the overwhelming surge. And now, Missouri Attorney General Eric Schmitt said Monday that his office obtained a temporary restraining order blocking the Biden administration from lifting Title 42.
As mining activity expands in northern Labrador, COVID-19's 'new normal' difficult to accept for Nunatsiavut Inuit communities
The Royal Caribbean cruise line has gotten rid of one controversial pandemic-era policy. Cruise lines have slowly returned to normal, or at least to near-normal, as vaccines and testing make the covid pandemic a less critical concern. It's not that the coronavirus pandemic has ended -- it most certainly hasn't and scary new variants are always possible. But Royal Caribbean ( ( (RCL) - CCL) - NCLH) - Get Norwegian Cruise Line Holdings Ltd.
Pharma shells out more than $300K to brother of top Biden aide in 3 months
Last year, controversy swirled around a slate of pharma companies that paid Jeff Ricchetti - the brother of longtime Biden advisor Steve Ricchetti - to lobby legislators and the executive office of the president. This year, it appears some companies are getting deeper into lobbying with a couple big names, according to a recent document dump from the US House of Representatives.
Researchers identified over 5,500 new viruses in the ocean, including a missing link in viral evolution
newannyart/iStock via Getty Images Plus The Research Brief is a short take about interesting academic work. The big idea VectorMine/iStock via Getty Images Plus An analysis of the genetic material in the ocean has identified thousands of previously unknown RNA viruses and doubled the number of phyla, or biological groups, of viruses thought to exist, according to a new study our team of researchers has published in the journal Science.
UGA team develops faster, cheaper COVID tests
A University of Georgia nanotechnology research groupentered the race to develop a rapid test for COVID-19 in August 2020, running experiments on a new sensor for an American manufacturing company. The group, led by Yiping Zhao and Ralph Tripp, tested nanotechnology-based optical sensors designed for COVID-19 detection and saw the potential for their home-grown technology.
Moderna expands product line, global efforts, with IAVI partnership
Blend Labs CEO Nima Ghamsari is a betting man. In his early 20s, he bet that online poker could cover his tuition at Stanford and then some. He was right. In 2008, as the financial crisis was unfolding, he landed a job at secretive big data startup Palantir, where he learned that the $10 trillion mortgage industry was still in the Stone Age technologically.
Pfizer bulks up in RSV with $525m takeover of ReViral
Pfizer is looking to follow its vaccine/oral antiviral combination that has proved so profitable in COVID-19 with a similar approach in respiratory syncytial virus (RSV). The drugmaker is in the latter stages of development for its RSV vaccine with phase 3 results due shortly, and has just snapped up an oral antiviral for the disease by acquiring its developer ReViral in a $525 million deal.
Abortion pills are just as safe to prescribe based on a patient's medical history as after an in-person exam, new research finds
There is no doubt that Pfizer's approach to COVID-19 has been a success: the first COVID-19 vaccine in partnership with BioNTech to be authorized in the United States, one of the predominant vaccines around the world, and a successful oral antiviral therapy, all without taking direct R&D funds from the government via Operation Warp Speed. And the company has benefitted handsomely, as has its chief architect, Albert Bourla. For that and more COVID-19 news, continue reading.
As the World is on the Brink of Chaos, the Mighty Dollar is Back
Authored by Michael Snyder via TheMostImportantNews.com, Everyone needs to start paying attention to this crisis, because America's rapidly growing bird flu pandemic is going to deeply affect all of us at the grocery store. This pandemic began on February 8th when a confirmed case of HPAI was confirmed in a domestic flock, and on March 9th I published an article that discussed the fact that nearly 2.8 million birds (mostly chickens and turkeys) had already died.
the likely course of BA.2 in the US
- by New Deal democrat [Note: I am having a major issue with formatting photos today, which will be readily apparent. I will fix this as soon as I am able.] This is the second part of my discussion of the likely US trajectory of the BA.2 Omicron subvariant. Part one was Friday, and if you missed it, here is the link. First, a brief update. Cases in the US are now slightly below 30,000. This is the lowest since last August except for two days after Thanksgiving. Deaths have declined to 866.
Spider Silk Stabilizes Cancer-Suppressing Protein and More
Emilija Manevska/Moment via Getty Images The Conversation is running a series of dispatches from clinicians and researchers operating on the front lines of the coronavirus pandemic. You can find all of the stories here. I don a gown, gloves and a mask to enter the hospital room of a new mother who is sick with COVID-19. She lies in bed, exhausted between coughing spells; her day-old infant rests comfortably across the room.
Dow Jones, S&P 500 Mixed; GameStop (GME) To Launch NFT Marketplace
Rivian's share price has fallen sharply, and after walking back an ill-advised price increase, the EV maker has a tough slog ahead. Everything seems to be going against Rivian (RIVN) - Get Rivian Automotive, Inc. Class A Report. Until recently the electric-vehicle manufacturer presented as a key challenger to the throne of Tesla (TSLA) - Get Tesla Inc Report. But two key stumbles -- involving pricing and production -- have severely clouded Rivian's path forward.
Oil and gold both pare losses after Putin says Ukraine not serious in finding acceptable solution
It was a very eventful week. We can't possibly get to everything and still keep things brief. Keep in mind the Stalin quote - " there are decades where nothing happens; and there are weeks where decades happen." when trading these markets. The Russia/Ukraine war is still going strong with the Russian troops just nine miles from Kyiv, according to recent reports.
Why we trust experts
Many countries around the world that appeared to have kicked COVID-19, are reporting surges, largely the result of the so-called "stealth" Omicron variant, BA.2. For that story and more, continue reading. Omicron BA.2 Appears to be Surging Globally Although numbers appear to be dropping in the U.S., other countries around the world are seeing increases of COVID-19 cases, particularly in the UK, Germany, France, Switzerland, Italy and the Netherlands.
Smith & Wesson Shares Plunge As CEO Admits Demand For Guns Has "Cooled Significantly"
Overview Associate Professor Kazuhiro Takahashi and Tomoya Maeda (a second-year Master's student) and other members of the Department of Electrical and Electronic Information Engineering at Toyohashi University of Technology have developed a semiconductor sensor capable of detecting ultra-low concentrations of tumor markers, on chips made using semiconductor micromachine technology.
New discovery may help reduce side effects of multiple sclerosis drugs
Credit: Dr. Xin-Yun Huang Investigators from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center have discovered how a drug for multiple sclerosis interacts with its targets, a finding that may pave the way for better treatments. The study, published Feb.
Neurons Key to Parkinson's ID'ed, New ALS Mechanism Discovered
Authored by Zachary Stieber via The Epoch Times, A growing number of experts are urging the U.S. government to formally recognize natural immunity, or the protection given by recovering from COVID-19. More experts are arguing that the Centers for Disease Control and Prevention's (CDC) recommended vaccination schedule should feature fewer doses-or none at all-for people who have contracted COVID-19 and survived.
CWB reports first quarter 2022 financial and strategic performance
CHARLOTTE, N.C., Feb. 25, 2022 /PRNewswire/ -- LendingTree, Inc. (NASDAQ: TREE), operator of LendingTree.com, the nation's leading online financial services marketplace, today announced results for the quarter ended December 31, 2021. The Company has posted a letter to shareholders on its investor relations website at investors.lendingtree.com. "As a company, we are galvanized around the strategy we shared with you recently at our Investor Day," said Doug Lebda, Chairman and CEO.
How data-driven decision making is defining the future of airport operational excellence
The following article was published by Future Travel Experience Airport Intelligence's Korijn Defever shares key takeaways from a recent workshop on the future of operational excellence, which took place during FTE Global 2021. Achieving operational excellence has always been at the core of airport operations, but with the aviation business undergoing dramatic changes due to the COVID-19 crisis, new approaches are needed to manage operations in the most efficient possible way.
Geopolitical Risk Could Sideline The Fed
"Geopolitical Risk" could well be a reason for the Fed to slow-roll tightening monetary policy in March. With Russia invading Ukraine, such would not be the first time that the Fed used "geopolitical risk" to remain cautious on changes to monetary policy.
How new data capabilities can supercharge clinical research
The past two years have shone a spotlight on the UK life sciences industry. Pharma companies are now household names, having been thrust into the public's consciousness after dominating the headlines through the pandemic. The UK pharma sector should emerge from COVID-19 with a great deal of goodwill in the bank, especially after rapidly developing vaccines that are helping to steer the world out of the pandemic.
Uh-Oh Labs develops tech for accurate COVID home tests and beyond
Biotech startup Uh-Oh Labs wasn't so much bootstrapped in its early days as it was deadlifted. Founder and CEO Cameron Ball was bankrolling his enterprise...
Texas Sues Biden Admin Over Federal Mask Mandate On Planes, Public Transport
Do You Have These Top Dividend Stocks On Your February 2022 Watchlist? With the stock market volatility amid escalating tensions between Russia and Ukraine, investors could be re-evaluating their current strategies. For those looking to take a more defensive stance, dividend stocks could be worth considering. After all, more consistent gains in the form of dividends would be a go-to for some.
73% of Americans Likely Immune to Omicron
Northwestern University synthetic biologists have developed a low-cost, easy-to-use, hand-held device that can let users know - within mere minutes - if their water is safe to drink. The new device works by using powerful and programmable genetic networks, which mimic electronic circuits, to perform a range of logic functions.
Happy birthday! The bloody mary turns 98
Ferdinand Petiot claimed to have invented the bloody mary in 1921, well before any of the later claims. He was working at the New York Bar in Paris at the time, a frequent hangout for Ernest Hemingway and other American migrants. Around 1920, émigrés escaping the Russian Revolution began arriving in Paris, bringing with them vodka and caviar. So Petiot decided to have some fun with it, and began experimenting with the new spirit since he found it tasteless.
Hangover Heaven: The top 7 best bloody marys in Forsyth County
A celery stalk and celery salt. Pepper. Olives. Lemons, limes, or both. Bacon — either crispy, candied, or peppered. Shrimp. Chicken tenders. Hamburgers. Pepperoni sticks. Asparagus. Waffles. It seems that almost anything can garnish a bloody mary these days. But is there a right or wrong way to make one? Can a bartender go too far?
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Mark
Contact Mark, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack